Event

Presented by The Cancer Center at Cooperman Barnabas Medical Center

2 AMA PRA Category 1 Credits^TM

Target Audience

Internal Medicine, Family Practice, Endocrinologist, ENTs, Medical Oncology, Radiation Oncology, Nurses and Allied Health Professionals.

Learning Objectives

• Understand the increasing incidence of thyroid malignancy.
• Understand thyroid sonography in benign and malignant disease.
• Recognize the relative slow growth and low mortality of thyroid malignancy.
• Understand the basics of surveillance and management of thyroid nodules.
• Identify papillary thyroid cancer: molecular diagnosis, prognosis, and treatment.
• Define molecular testing, options available for molecular testing and result management.
• Understand the American Joint Committee on Cancer (AJCC) thyroid cancer staging updates.

Agenda

Moderator: Bryant Lee, MD, Chief, Head and Neck Oncology, Cooperman Barnabas Medical Center

Overview and Prevalence of Thyroid Nodules and Malignancy
Bryant Lee, MD, Chief, Head and Neck Oncology, Cooperman Barnabas Medical Center

Sonography of Thyroid Disease
Alan G. Dembner, MD, Chief, Diagnostic Ultrasound, Cooperman Barnabas Medical Center

Papillary Thyroid Cancer: Molecular Diagnosis, Prognosis, and Treatment
David Bleich, MD, Chief, Division of Endocrinology, Diabetes & Metabolism, Program Director, Endocrinology, Diabetes & Metabolism, Professor of Medicine – Rutgers New Jersey Medical School

The Role of Molecular Testing in Thyroid Fine Needle Aspirations
Chan (Richard) Park, MD, Associate Professor of Otolaryngology, Rutgers-New Jersey Medical School

Continuing Medical Education Credit

AMA Credit Designation Statement Cooperman Barnabas Medical Center designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement Cooperman Barnabas Medical Center is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing medical education for physicians.

Disclosure Policy It is the policy of Cooperman Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity and scientific rigor in all CME sponsored educational activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devises. This information will be available as part of the activity material.

Faculty Disclosures: No relevant financial relationship(s)

Acknowledgement of Commercial Support: No commercial support was provided for this continuing educational activity.

“Patient Safety Committee Work Product - Confidentiality Protection and Restrictions on Disclosure Pursuant to N.J.S.A. 26:2H -12.25b. & N.J.A.C. 8:43E-10.0”

Registration: There is no fee to participate in this symposium, but online registration is required by September 17, 2019.